Patria Investments Limited (PAX): A Bear Case Theory

Core Thesis - A bearish thesis on Patria Investments Limited (PAX) highlights significant operational and financial concerns, suggesting the company may be overstating performance and masking losses [1][2][8] Financial Performance - As of February 9th, PAX's share price was $14.57, with trailing and forward P/E ratios of 20.91 and 8.14 respectively [1] - The firm has approximately USD 50 billion in assets under management (AUM) [2] Investment Concerns - Key holdings are distressed and marked at extreme premiums compared to listed peers, including a pharmaceutical distributor valued at 15x EV/EBITDA despite bonds trading near 50 cents on the dollar [3] - Other major investments include a loss-making hospital chain and a struggling renewables platform, marked at multiples significantly above market norms [3] Financial Engineering - Patria appears to sustain performance fees through circular internal transactions, asset shuffling, and questionable exits, such as a water desalination plant moved between its own funds [4] - Fundraising has relied on prepayments to limited partners (LPs) and large anchor commitments from affiliated entities, masking weak third-party demand [4] Governance and Management Issues - Governance concerns are elevated, including a CFO resignation, unexplained auditor change, high employee turnover, and the exit of Blackstone's 40% stake, which removed prior external validation [5] Debt and Dividend Sustainability - The firm's reliance on debt, deferred payments, and synthetic earnings to support AUM growth and share buybacks raises risks regarding dividend sustainability, especially in a high-interest Brazilian macro environment [6] - PAX's valuation appears stretched, with a 3.5% yield offering limited upside relative to the structural and operational risks faced by investors [6]